Registries of parathyroid glands diseases in the Russian Federation
https://doi.org/10.14341/probl12803
Abstract
The most important and effective way to organize nationwide the healthcare, as well as monitoring and routing for patients with endocrine diseases, is the creation of an unified medical record (Endocard). The Endocard is also aimed at maximizing the opportunity for professionals and researchers on various scientific issues. Registries are the potential informational and analytical platform to achieve this goal. They include the basic information on the epidemiological and clinical features of the most severe diseases such as diabetes mellitus. Given the lack of large-scale epidemiological data on the parathyroid glands pathology — primary hyperparathyroidism and hypoparathyroidism — the registers of these diseases that collects a common dataset and clinician and patient reported outcomes are of particular interest.
About the Authors
N. G. Mokrysheva
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Natalia G. Mokrysheva, MD, PhD, Professor
eLibrary SPIN: 5624-3875
Moscow
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
E. V. Kovaleva
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Elena V. Kovaleva, MD
11 Dm. Ulyanova street, 117036 Moscow
eLibrary SPIN: 7387-6791
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
A. K. Eremkina
Endocrinology Research Center
Russian Federation
Competing Interests:
Russian Federation
Anna K. Eremkina, MD, PhD
eLibrary SPIN: 8848-2660
Moscow
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
References
1. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-3569. doi: https://doi.org/10.1210/jc.2014-1413
2. Dedov II, Melnichenko GA, Mokrysheva NG, et al. Primary hyperparathyroidism: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2017;62(6):40-77. doi: https://doi.org/10.14341/probl201662640-77
3. Paik JM, Curhan GC, Taylor EN. Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ. 2012;345:e6390-e6390. doi: https://doi.org/10.1136/bmj.e6390
4. Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993-2001: An Update on the Changing Epidemiology of the Disease. J Bone Miner Res. 2005;21(1):171-177. doi: https://doi.org/10.1359/JBMR.050910
5. Yu N, Donnan PT, Murphy MJ, Leese GP. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol (Oxf ). 2009;71(4):485-493. doi: https://doi.org/10.1111/j.1365-2265.2008.03520.x
6. Kukora JS, Zeiger MA, Clark OH, et al. The American Association of Clinical Endocrinologists and The American Association of Endocrine Surgeons Position Statement on The Diagnosis and Management of Primary Hyperparathyroidism. Endocr Pract. 2005;11(1):49-54. doi: https://doi.org/10.4158/EP.11.1.49
7. Bone HG, Wagman RB, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and openlabel extension. Lancet Diabetes Endocrinol. 2017;5(7):513-523. doi: https://doi.org/10.1016/S2213-8587(17)30138-9
8. Pepe J, Cipriani C, Sonato C, et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol. 2017;177(6):R297-R308. doi: https://doi.org/10.1530/EJE-17-0485
9. Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19. doi: https://doi.org/10.1007/s00198-016-3716-2
10. Mokrysheva NG, Mirnaya SS, Dobreva EA, et al. Primary hyperparathyroidism in Russia according to the registry. Problems of Endocrinology. 2019;65(5):300-310. (In Russ.) doi: https://doi.org/10.14341/probl10126
11. Bollerslev J, Rejnmark L, Marcocci C, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1-G20. doi: https://doi.org/10.1530/EJE-15-0628
12. Khan AA, Koch CA, Van Uum S, et al. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. Eur J Endocrinol. 2019;180(3):P1-P22. doi: https://doi.org/10.1530/EJE-18-0609
13. David K, Moyson C, Vanderschueren D, Decallonne B. Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study. Eur J Endocrinol. 2019;180(1):71-78. doi: https://doi.org/10.1530/EJE-18-0580
14. Bilezikian JP, Khan A, Potts JT, et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26(10):2317-2337. doi: https://doi.org/10.1002/jbmr.483
15. Kovaleva EV, Ajnetdinova AR, Eremkina AK, Mokrysheva NG. Evaluation of chronic hypoparathyroidism course according to the Database of Endocrinology Research Centre. Problems of Endocrinology. 2020;66(5):7-14.(In Russ.) doi: https://doi.org/10.14341/probl12675
Supplementary files
|
|
1. Figure 1. Current distribution of patients with PHPT according to the phase of the course of the disease. | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(76KB)
|
Indexing metadata ▾ | |
|
|
2. Figure 2. Distribution of patients with hypoparathyroidism by disease etiology. | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(109KB)
|
Indexing metadata ▾ | |
Review
For citations:
Mokrysheva N.G., Kovaleva E.V., Eremkina A.K. Registries of parathyroid glands diseases in the Russian Federation. Problems of Endocrinology. 2021;67(4):4-7. (In Russ.) https://doi.org/10.14341/probl12803
Views:
1311
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
